HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fuller, M. J. Articles by Zajac, A. J. Search for Related Content PubMed PubMed Citation Articles by Fuller, M. J. Articles by Zajac, A. J.

Ablation of CD8 and CD4 T Cell Responses by High Viral Loads¹

Department of Microbiology, University of Alabama, Birmingham, AL 35294

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
To evaluate the impact of sustained viral loads on anti-viral T cell responses we compared responses that cleared acute lymphocytic choriomeningitis virus infection with those that were elicited but could not resolve chronic infection. During acute infection, as replicating virus was cleared, CD8 T cell responses were down-regulated, and a pool of resting memory cells developed. In chronically infected hosts, the failure to control the infection was associated with pronounced and prolonged activation of virus-specific CD8 T cells. Nevertheless, there was a progressive diminution of their effector activities as their capacity to produce first IL-2, then TNF-, and finally IFN- was lost. Chronic lymphocytic choriomeningitis virus infection was also associated with differential contraction of certain CD8 T cell responses, resulting in altered immunodominance. However, this altered immunodominance was not due to selective expansion of T cells expressing particular TCR V segments during chronic infection. High viral loads were not only associated with the ablation of CD8 T cell responses, but also with impaired production of IL-2 by virus-specific CD4 T cells. Taken together, our data show that sustained exposure to high viral loads results in the progressive functional inactivation of virus-specific T cell responses, which may further promote virus persistence.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Cells of the adaptive immune system, including B cells, CD4 T cells, and CD8 T cells, act cooperatively to combat viral infections (1, 2, 3, 4, 5). Virus clearance represents an immunological success story and ideally renders the host immune to reinfection by the same pathogen. However, certain infections are not completely eradicated, but are instead brought under control at a steady state level (1, 2, 3, 4, 6). This suggests that under certain conditions the immune response is ineffective and the biological consequence of this is virus persistence. A combination of factors can contribute to virus persistence, including the deployment of immune evasion mechanisms by the pathogen and the inability of the host to induce or sustain appropriate immunological effector mechanisms (7, 8, 9, 10, 11).

CD8 T cells are key mediators of the immune response against viruses (1, 3, 4, 10). During a typical acute viral infection, naive CD8 T cells undergo massive proliferation as they differentiate and acquire effector capabilities (3, 4, 12, 13, 14, 15, 16). As the infection is resolved, the pool of virus-specific CD8 T cells contracts, homeostasis is restored, and a stable population of memory cells is established (1, 3, 4). The virus-specific CD8 T cells that are elicited by an acute infection are not usually a monoclonal population of cells, but instead are comprised of oligoclonal subsets that recognize a variety of distinct viral epitopes (17, 18, 19, 20). In addition, CD8 T cells can use multiple effector functions to control viral infections (1, 3, 4). They can kill cells that have become infected with a virus, primarily by secreting perforin and serine esterases (granzymes) (3, 21, 22, 23, 24, 25). CD8 T cells can also control viral infections by inducing an anti-viral state through the release of cytokines such as IFN- and TNF- (26, 27).

The failure to mount an adaptive immune response is not a prerequisite for the establishment of chronic infections, as a hallmark of the acute phase of many persistent infections is the induction of clearly discernable populations of virus-specific CD8 T cells (3, 4, 28, 29, 30). These responses can, however, fail to clear the virus for a variety of reasons, including epitope escape, the skewed maturation of memory CD8 T cells, the deletion of cells reactive against particular viral Ags, and selective defects in cytokine production and/or cytotoxicity (9, 28, 29, 31, 32, 33, 34, 35, 36, 37, 38, 39).

Viral infections also induce CD4 T cell responses, and because of their multifaceted roles, these lymphocytes are critical for the successful resolution of many viral infections. CD4 T cell-derived cytokines promote T cell proliferation and activation, help B cell responses, and induce Ig class switching (2, 4, 5, 40, 41). CD4 T cells can also activate dendritic cells, exhibit regulatory properties, and, under certain circumstances, elaborate cytotoxic effector functions (2). Our previous studies have shown that CD4 T cell-deficient mice cannot control infection with certain isolates of lymphocytic choriomeningitis virus (LCMV)³ (29, 42). Under these conditions virus-specific CD8 T cell responses are induced, but their effector functions diminish over time (42). This suggests that the combination of persistently high viral burdens and the lack of CD4 T cell help negatively regulates CD8 T cell responses. Nevertheless, the contribution of high viral load vs absence of CD4 T cell help in silencing CD8 T cell responses remains unclear.

The purpose of the current study was to dissect the interplay between viral load and CD4 T cell responses in maintaining virus-specific CD8 T cell activity. Perforin-deficient (PKO) mice have intact CD4 and CD8 T cell compartments, but because of their inability to express perforin they cannot control isolates of LCMV that cause only an acute infection in normal adult mice (6, 21, 23, 43). This provided us with an attractive system to skew an acute to a chronic infection in hosts that possess CD4 T cells and determine the impact of high viral loads on virus-specific T cell responses.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Mice and virus

C57BL/6 (B6) mice and perforin-deficient C57BL/6-Pfp^tm1Sdz (PKO) mice (21) (both H-2^b) as well as DBA/2 mice (H-2^d) were purchased from The Jackson Laboratory (Bar Harbor, ME). Animals were bred and maintained in accredited facilities at University of Alabama, Birmingham, AL). Male and female mice between 6–10 wk of age were used.

The Armstrong isolate of LCMV was provided by Dr. R. Ahmed (Emory University, Atlanta, GA). Plaque-purified viral isolates were propagated in BHK-21 cells. Mice were infected by i.p. inoculation with 2 x 10⁵ PFU of LCMV-Armstrong in a volume of 0.5 ml and were sacrificed at the indicated time points. The titers of viral stocks and serum samples were determined by plaque assays using Vero cell monolayers (44).

Cell preparation

Freshly explanted spleens were disrupted into single-cell suspensions using wire mesh screens. Erythrocytes were subsequently removed by lysis using 0.83% (w/v) NH₄Cl. After washing, splenocytes were finally resuspended in RPMI 1640 medium supplemented with 10% FCS, 50 µM 2-ME, 100 U/ml penicillin, and 100 µg/ml streptomycin.

Preparation of MHC class I tetramers

The methodology for preparation of MHC class I tetramers was modified from the protocol described by Altman and coworkers (45). Recombinant MHC class I molecules fused to a BirA substrate peptide were produced in Escherichia coli BL21 (DE3) cells, and expression was induced with isopropyl -D-thiogalactopyranoside. Recombinant ₂-microglobulin was similarly produced. After 4 h of induction, bacteria were harvested by centrifugation at 2800 x g, and cell pellets were stored at -70°C. Thawed bacterial pellets were resuspended in 100 mM NaCl, 100 mM NaH₂PO₄, and 5% (v/v) glycerol and were disrupted using a French press. Suspensions were then centrifuged at 9800 x g for 1 h at 4°C. Inclusion body pellets were resuspended in 50 mM Tris, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.1% (w/v) NaN₃, and 0.5% (v/v) Triton X-100 (wash buffer) and subsequently centrifuged at 4000 x g for 20 min. Pellets were washed twice more in wash buffer containing 0.5% (v/v) Triton X-100, twice in wash buffer without Triton X-100, and once in water. Recombinant proteins were solubilized in 8 M urea, 10 mM EDTA, 0.1 mM DTT, and 25 mM MES (pH 6.0), aliquoted, and snap-frozen. MHC-peptide complexes were generated by folding class I H chains in vitro with ₂-microglobulin and defined LCMV-derived peptide epitopes as previously described. Reaction mixtures were concentrated using a stirred ultrafiltration cell (Amicon, Bedford, MA) with a 30-kDa exclusion limit membrane. Buffer exchange into 200 mM NaCl, 5 mM MgCl₂, and 100 mM Tris (pH 7.6) was accomplished using PD-10 desalting columns (Amersham Pharmacia Biotech, Piscataway, NJ). Enzymatic biotinylation reactions using BirA were allowed to proceed for 18 h at 23°C. Reaction mixtures were then applied to a Sepharose G-75 column (Amersham Pharmacia Biotech), and fractions containing biotinylated class I-₂-microglobulin-peptide complexes were pooled and exchanged into 20 mM Tris (pH 8.0) using centrifugal filtration devices (Millipore, Bedford, MA). The complexes were further purified by ion exchange chromatography using a QM-Sepharose column (Amersham Pharmacia Biotech). Appropriate fractions were concentrated and dialyzed against PBS containing 2 mM EDTA, 1 µg/ml of leupeptin, 1 µM pepstatin, and 200 µM PMSF (Sigma-Aldrich, St. Louis, MO). The complexes were tetramerized by the stepwise addition of allophycocyanin-conjugated streptavidin (Molecular Probes, Eugene, OR).

MHC class I tetramer staining

Splenocyte preparations were stained in PBS containing 2% (w/v) BSA and 0.2% (w/v) NaN₃ (FACS buffer). Samples were costained with anti-CD43-FITC Abs (clone 1B11; BD PharMingen, San Diego, CA) together with allophycocyanin-conjugated MHC class I tetramers complexed with either the H-2D^b-restricted LCMV epitopes gp33–41, nucleoprotein (NP)_396–404, and gp276–286 or the H-2K^b-restricted epitope NP_205–212. For costains with H-2D^b tetramers, the anti-CD8-PE Ab clone 53-6.7 (BD PharMingen or eBioscience (San Diego, CA)) was included; however, for costains with the H-2K^b (NP_205–212) tetramer the anti-CD8-PE Ab clone CT-CD8a (Caltag, Burlingame, CA) was used. After staining, cells were washed three times in FACS buffer and fixed in PBS containing 2% (w/v) paraformaldehyde. Flow cytometry was performed using a FACSCalibur instrument (BD Biosciences, San Jose, CA), and data were analyzed using the computer program CellQuest.

Cytokine analysis

Stimulations and intracellular cytokine analysis were performed essentially as previously described (46). Briefly, splenocytes were either untreated or were stimulated with LCMV-derived peptide epitopes (1 µg/ml for H-2D^b or H-2K^b restricted epitopes and 10 µg/ml for I-A^b restricted epitopes). The intracellular accumulation of cytokines was facilitated by the addition of either brefeldin A for CD8 T cell responses (Golgiplug; BD PharMingen) or monensin for CD4 T cell responses (Golgistop; BD PharMingen). Cells were cultured for 5–6 h at 37°C, and surface and intracellular stainings were performed. The Abs used were anti-CD8-PE or -PerCP (clone 53-6.7), anti-CD4-PE (clone RM4-5), anti-IL-2-FITC or -PE (clone JES6-5H4), anti-IL-4-allophycocyanin (clone 11B11), anti-IL-10-allophycocyanin (clone JES5-16E3), anti-IFN--FITC or -allophycocyanin (clone XMG1.2), and anti-TNF--allophycocyanin (clone MP6-XT22). Conjugated Abs were purchased from either BD PharMingen or eBioscience.

TCR V usage

TCR V gene usage was evaluated by flow cytometry using a panel of anti-TCR V Abs. Splenocytes (5 x 10⁵–10⁶) were treated for 15 min with 1 µg/sample of anti-CD16/CD32 Abs (Fc Block; BD PharMingen). Subsequently, cocktails containing anti-CD8-PE Abs (clone 53-6.7), D^b (gp276–286) tetramers, and a panel of FITC-conjugated anti-TCR V Abs were added. Anti-TCR V2, -3, -4, -5.1/5.2, -6, -7, -8.1/8.2, -8.3, -9, -10b, -11, -12, -13, and -14 (clones B20.6, KJ25, KT4, MR9-4, RR4-7, TR310, MR5-2, 1B3.3, MR10-2, B21.5, RR3-15, MR11-1, MR12-3, and 14-2, respectively) were all obtained from BD PharMingen. After staining, cells were washed three times and fixed in PBS containing 2% (w/v) paraformaldehyde before flow cytometric analysis.

N-benzyloxycarbonyl-L-lysine thiobenzyl ester, hydrochloride (BLT) esterase release assays

Granzyme A activity was determined by BLT esterase release assays, performed as previously described with modifications (47, 48). Splenocytes prepared from B6 and PKO mice 8 days after LCMV infection were seeded into 96-well plates. Cultures were either left untreated or stimulated with non-fluorochrome-conjugated H-2D^b tetramers complexed with either LCMV-gp33–41 or LCMV-NP_396–404 epitopes (10 µg/ml) or by the addition of 50 ng/ml PMA (Sigma-Aldrich) and 500 ng/ml ionomycin (Calbiochem, San Diego, CA). To determine total BLT esterase content, unstimulated cells were lysed with Triton X-100 (0.09% final concentration) and processed as described below. After 5 h, plates were centrifuged at 74 x g for 5 min. Then 50 µl of supernatant was collected from each well and mixed with 150 µl of PBS containing 0.26 mM BLT, 0.29 mM 5,5'-dithio-bis-(2-nitrobenzoic acid), and 0.013% Triton X-100. Colorimetric reactions were allowed to proceed for 1 h at 37°C, and BLT esterase activity was measured by reading the A₄₁₂ using a microplate reader (Molecular Devices, Sunnyvale, CA). The percentage of BLT esterase release was calculated using the following formula: % BLT esterase release = 100 x [(experimental release - spontaneous release)/(total release - spontaneous release)].

Mixed lymphocyte reactions

Mixed lymphocyte reactions were set up essentially as previously described (49). Briefly, splenocytes from DBA/2 mice, prepared as described above, were irradiated (2000 rad) and mixed at a 1:1 ratio with responder splenocytes from either B6 or PKO mice. Cells were cultured in 24-well cluster plates (8 x 10⁶ total cells/well) for 5 days at 37°C in 6% CO₂. After this time viable cells were collected by centrifugation over a layer of Histopaque-1083 (Sigma-Aldrich). BLT esterase release was then determined as described above following a 5-h stimulation with either PMA (50 ng/ml) and ionomycin (500 ng/ml) or plate-bound hamster anti-mouse CD3 Abs (clone 145-2C11).

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Maintenance of activated virus-specific CD8 T cells in persistently infected hosts

Previous studies have demonstrated that because of their inability to express perforin, a crucial mediator of cell-mediated cytotoxicity, PKO mice cannot resolve infections with isolates of LCMV that cause only an acute infection in normal mice (21, 23). As expected, no viremia was detectable in B6 mice >8 days after infection with the Armstrong isolate of LCMV (data not shown). By contrast, PKO mice became persistently infected, and serum virus titers of >10⁴ PFU/ml were detectable by 1 mo after infection (Fig. 1). LCMV infection of PKO mice was, however, not asymptomatic. During the second week following inoculation PKO mice developed hunched posture, ruffled fur, and lethargic behavior, and approximately one-third of these mice died between 2 and 4 wk after injection.

View larger version (17K): [in this window] [in a new window]   FIGURE 1. Chronic LCMV infection of PKO mice. Serum virus titers were determined at various times following infection of PKO mice with the Armstrong isolate of LCMV. Titers of individual mice are shown, and the limit of detection is 50 PFU/ml.

View larger version (93K): [in this window] [in a new window]   FIGURE 2. Altered CD8 T cell activation, specificity, and cytokine production in chronically infected hosts. a and b, On the indicated days post-LCMV-Armstrong infection, virus-specific CD8 T cells were visualized by staining with MHC class I tetramers complexed with four different LCMV peptide epitopes. Activation was assessed by examining forward light scatter properties (FSC; cell size) and expression of the activation-associated isoform of CD43 (1B11) on gated tetramer+ CD8 T cells. Flow cytometric profiles are shown for splenocytes from acutely infected B6 mice (a) and chronically infected PKO mice (b). For comparison, profiles of total splenic CD8 T cells from naive B6 and PKO mice are shown (c and d, respectively). a and b, The values given represent the percentages of CD8 T cells that stain positively with the indicated tetramer and are either CD43high or CD43low. c and d, The values represent the percentages of CD43high and CD43low CD8 T cells in naive mice. e and f, The ability of virus-specific CD8 T cells to produce IFN- and TNF- was determined by intracellular cytokine analysis following a 5- to 6-h stimulation in vitro using the defined peptide epitopes indicated. Freshly explanted splenocytes from acutely infected B6 mice (e) or chronically infected PKO mice (f) were analyzed on days 9, 14, and 110 postinfection. Gated CD8 T cells are shown, and the values given represent the percentages of CD8 T cells in the upper right and lower right quadrants that produce both IFN- and TNF- or only IFN-, respectively. All panels show representative data from three to seven mice analyzed at each time point.

Loss of CD8 T cell effector activity

Since virus-specific CD8 T cells remained detectable over time in LCMV-infected PKO mice, we examined whether chronic exposure to high viral loads altered the capacity of these cells to produce effector cytokines. As expected, LCMV-specific IFN-- and TNF--producing CD8 T cells were readily detectable in acutely infected B6 mice (Fig. 2e) (52, 53). By 9 days after infection significant responses to the five MHC class I-restricted epitopes tested were apparent. Many of these CD8 T cells produced both IFN- and TNF-; however, a fraction produced IFN- only. By 14 days after infection, as replicating virus was cleared, the virus-specific CD8 T cells retained the potential to produce IFN- and TNF- and remained fully functional even after returning to a resting state. This is corroborated by comparing the numbers of splenic virus-specific CD8 T cells identified by tetramer staining with the numbers of epitope-specific, IFN--producing CD8 T cells (Fig. 3a).

View larger version (30K): [in this window] [in a new window]   FIGURE 3. Enumeration of virus-specific CD8 T cell responses during acute and chronic LCMV infection. The kinetics of CD8 T cell responses to four defined LCMV-specific epitopes were determined following LCMV-Armstrong infection of either B6 (a) or PKO (b) mice. At various times after infection the total numbers of splenic CD8 T cells specific for each epitope were determined by costaining with anti-CD8 Abs and MHC class I tetramers (). Functional epitope-specific CD8 T cells were enumerated by intracellular cytokine analysis for IFN- following a 5- to 6-h stimulation with peptide epitopes (). Mean values are shown for two to seven mice at each time point, and error bars represent SDs.

The kinetics of virus-specific CD8 T cell responses in acutely infected B6 mice and chronically infected PKO mice are compared in Fig. 3. In B6 mice, expansion, contraction, and memory phases of the anti-viral response are apparent, and there is an excellent correlation between the number of CD8 T cells visualized by tetramer staining and those that have the capacity to produce IFN- (Fig. 3a). Enumeration of virus-specific CD8 T cell responses in LCMV-infected PKO mice shows several differences between the responses in acutely and chronically infected hosts (Fig. 3b). Although virus-specific CD8 T cells are initially detectable in PKO mice, not all these cells are capable of producing IFN-. Between days 9 and 40 after infection the absolute number of virus-specific CD8 T cells declines in both acutely infected B6 mice and chronically infected PKO mice. In PKO mice, however, there is a disproportionate reduction in the number of IFN--producing cells as these virus-specific CD8 T cells lose their capacity to elicit anti-viral effector activity.

Although responses to multiple viral epitopes are detectable in both acutely infected B6 mice and chronically infected PKO mice, the magnitude of the response to each individual epitope is not equal. Instead, a hierarchy of immunodominant and subdominant responses becomes established (Figs. 2 and 3). In acutely infected B6 mice the gp33–41 and NP_396–404 responses are codominant, followed by the somewhat weaker gp276–286 response and the subdominant NP_205–212 response. During the course of chronic LCMV infection this epitope hierarchy changes. Although the initial burst sizes of the responses are similar in both B6 and PKO mice, the failure to control the infection is associated with differential contractions of certain specificities of CD8 T cells. H-2D^b-restricted NP_396–404-specific CD8 T cells are more prone to deletion in chronically infected hosts (Fig. 3). By contrast, in PKO mice, despite a severe functional impairment, the H-2D^b-restricted gp276–286-specific response contracts less and becomes immunodominant (Fig. 3b). Taken together these data show that chronicity results in sustained CD8 T cell activation and altered immunodominance; however, there is a progressive breakdown of effector functions as first TNF- and then IFN- production is lost.

IL-2 production and granzyme A activity by virus-specific CD8 T cells

Given the marked loss of IFN- and TNF- production by virus-specific CD8 T cells in chronically infected hosts, we checked for impairment of other CD8 T cell effector functions. Triple intracellular cytokine staining was used to determine IL-2, IFN-, and TNF- production by virus-specific CD8 T cells in both acutely infected B6 mice and chronically infected PKO mice (Fig. 4). Three major populations of cytokine-producing cells were identified. In B6 mice, at 8 days postinfection, CD8 T cells produced either only IFN-, IFN- and TNF-, or all three cytokines, IFN-, TNF-, and IL-2. By 85 days after infection the proportion of cells that produced only IFN- declined, and the proportion of CD8 T cells that produced all three cytokines, including IL-2, increased (Fig. 4a). In PKO mice, few, if any, CD8 T cells produced IL-2 at 8 days postinfection, but CD8 T cells that produced only IFN- or IFN- and TNF- were detectable. Analysis of virus-specific CD8 T cells in PKO mice on day 85 postinfection confirmed that these cells become unable to produce any of the cytokines tested for (Fig. 4b). Taken together with the results in Figs. 2 and 3, these data show that the failure to rapidly resolve the infection results in lost production of first IL-2, followed by TNF-, and finally IFN-.

View larger version (19K): [in this window] [in a new window]   FIGURE 4. Production of IL-2, IFN-, and TNF- by virus-specific CD8 T cells is lost during chronic LCMV infection. Production of the cytokines IL-2, IFN-, and TNF- by virus-specific CD8 T cells was assessed by intracellular cytokine staining following a 5- to 6-h stimulation with five different LCMV peptide epitopes. Splenocytes from acutely infected B6 mice (a) and chronically infected PKO mice (b) were analyzed on days 8 and 85 after infection. The percentages of gated CD8 T cells that express only IFN-, coexpress IFN- and TNF-, or express all three cytokines (IFN-, TNF-, and IL-2) are shown. Mean values are plotted for four to seven mice at each time point, and error bars represent SDs.

It has previously been reported that alloreactive T cells from PKO mice contain and release similar levels of granzyme A as alloreactive effectors from B6 mice (49). We confirmed these observations using H-2^b anti-H-2^d effector cells generated in 5-day mixed lymphocyte reactions. Alloreactive CD8 T cells from both B6 and PKO mice released similar levels of BLT esterase. Moreover, total BLT esterase levels in alloreactive PKO T cells were at least as high as those in alloreactive effector cells from B6 mice (data not shown). Overall these data suggest that the lower total levels of BLT esterase in CD8 T cells from chronically infected PKO mice are consistent with a more global functional impairment of these cells resulting from prolonged exposure to high viral loads.

TCR V gene usage by unresponsive CD8 T cells

As illustrated in Fig. 3, because of differential contraction, the gp276–286-specific CD8 T cell response becomes immunodominant in chronically infected PKO mice. To determine whether this altered epitope recognition profile resulted from the selection of particular clones or subsets of gp276–286-specific CD8 T cells, we compared TCR V usage by these cells at different stages of the immune response.

Naive CD8 T cells from control B6 and PKO mice show a similar pattern of TCR V gene usage, as determined using a panel of Abs specific for 14 different TCR V segments (Fig. 5a). By 8 days after infection, which corresponds to the effector phase of the immune response in normal mice, gp276–286-specific CD8 T cells are detectable, and the predominant TCR V genes used by this population include V10 and V8.1/8.2 (Fig. 5b). Similarly, an oligoclonal response was detectable during the contraction phase of the response, at 20 days after infection (Fig. 5c). The TCR V gene usage by gp276–286-specific CD8 T cells was also examined on days 110 and 121 postinfection. By this time a pool of fully functional memory CD8 T cells is established in B6 hosts, whereas in chronically infected PKO mice, gp276–286-specific cells are present, but have severely impaired effector capabilities. At this late time point, gp276–286-specific CD8 T cells in both B6 and PKO mice also predominantly used TCR V10 and V8.1/8.2 (Fig. 5d). Thus, no striking differences in TCR V gene usage are apparent between gp276–286-specific CD8 T cells with effector, memory, or unresponsive phenotypes (Fig. 5, b–d).

View larger version (14K): [in this window] [in a new window]   FIGURE 5. Effector, memory, and functionally unresponsive gp276–286-specific CD8 T cells display similar TCR V profiles. a, V gene usage by bulk CD8 T cells from naive B6 (x) and PKO () mice (n = 5) was determined by costaining with anti-CD8 Abs and a panel of 14 anti-TCR V mAbs. b–d, B6 and PKO mice were infected with the Armstrong isolate of LCMV, and V gene usage by splenic gp276–286-specific CD8 T cells was determined by costaining with anti-CD8 Abs, Db (gp276–286) tetramers, and a panel of anti-TCR V Abs. b and c, TCR V usage profiles of gp276–286-specific CD8 T cells prepared from B6 (x) and PKO () mice on days 8 (n = 3) and 20 (n = 4) postinfection. d, Composite data obtained at days 110 (x, ) and 121 (+, ) post infection of B6 mice (x and +; n = 4 at each time point) and PKO mice ( and ; n = 2 at each time point). Results of individual mice are shown.

Fig. 6 shows the intracellular cytokine staining profiles and enumeration of virus-specific I-A^b-restricted CD4 T cell responses at various times after acute or chronic LCMV infection of B6 and PKO mice, respectively. Responses to the gp61–80 epitope and subdominant NP_309–328 epitope were analyzed. As expected, acute infection of B6 mice elicited a Th1-type response (2, 6, 19, 54). By day 9 postinfection virus-specific CD4 T cells were detectable that produced both IFN- and IL-2 or only IFN-. At this time point 50% of the LCMV-specific CD4 T cells could produce IL-2. Both IL-2- and IFN--producing CD4 T cell responses remained detectable throughout the effector (day 9), contraction (day 14), and memory (day 110) phases of the response (Fig. 6, a and c).

View larger version (37K): [in this window] [in a new window]   FIGURE 6. Loss of IL-2 production by virus-specific CD4 T cells in chronically infected hosts. IL-2 and IFN- production by virus-specific CD4 T cells was analyzed by intracellular cytokine staining following stimulation with the I-Ab-restricted LCMV epitopes gp61–80 and NP309–328. Representative flow cytometry plots show cytokine production on days 9, 14, and 110 postinfection in acutely infected B6 (a) and chronically infected PKO (b) mice. Gated CD4 T cells are shown, and the values given represent the percentage of CD4 T cells in upper left and upper right quadrants that produce only IFN- or both IL-2 and IFN-, respectively. Kinetics of the virus-specific CD4 T cell responses were determined by enumerating total numbers of IFN--producing () and IL-2-producing () cells in the spleens of acutely infected B6 mice (c) and chronically infected PKO mice (d) on various days after infection. At each time point two to seven mice from each group were analyzed, and the means ± SD are plotted.

To determine whether virus persistence resulted in immune deviation and caused the responding CD4 T cells to acquire a Th2 phenotype, we assessed the ability of the virus-specific CD4 T cells to produce IL-4 and IL-10. No IL-4-producing gp61–80- or NP_309–328-specific CD4 T cells were detectable at any time following infection of either B6 or PKO mice (data not shown). A small fraction of gp61–80-specific IL-10-producing CD4 cells were visualized in both B6 mice (0.16 ± 0.06%) and PKO mice (0.59 ± 0.12%) at 9 days postinfection. However, this activity was not maintained over time, and by day 20 only background levels of IL-10 production were detectable in either host (data not shown). As a positive control we validated our intracellular cytokine staining using a bulk DO11.10 Th2 cell line and demonstrated that, as expected, these cells produced IL-4 and IL-10 (data not shown).

Taken together, these data show that acute LCMV infection induces a marked, virus-specific, Th1 CD4 T cell response. The failure of PKO mice to clear LCMV infection does not result in a shift of this response to a Th2 phenotype; however, prolonged exposure to high viral loads ablates IL-2 production by the responding CD4 T cells.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
The goal of the current study was to determine how persistent exposure to high viral loads impacts the maintenance and function of virus-specific T cell responses. To address this we took advantage of PKO mice that contain both CD4 and CD8 T cell subsets, but become persistently infected with LCMV (21, 23). In this way we were able to initiate an acute or chronic infection using the same viral isolate and perform a comparative analysis of virus-specific CD8 and CD4 T cell responses. Our findings reveal several key differences between T cell responses that successfully resolve acute infections and those that are induced, but fail to control chronic infections. Notably, our data show that the failure to rapidly resolve LCMV infection in PKO mice results in marked defects in both virus-specific CD4 and CD8 T cell responses. In the case of CD4 T cell responses, virus persistence was associated with the loss of IL-2 production. Multiple virus-specific CD8 T cell responses were initially induced in PKO mice; however, unlike their counterparts in acutely infected hosts, these cells were maintained in an activated state, but progressively lost effector functions. The immunodominance of the virus-specific CD8 T cell population was also altered and could be attributed to differential contraction of certain specificities of T cells following the peak of the response. Taken together these data suggest that sustained exposure to high viral loads has a compounding effect, resulting in the progressive functional inactivation of virus-specific T cell responses, which, in turn, further promotes virus persistence.

Numerous viral infections, including LCMV infection, induce a marked virus-specific CD8 T cell response (3, 4, 12, 13, 14, 15, 16). The current study shows that pronounced expansion and activation of multiple virus-specific CD8 T cell responses occur during the first week of LCMV-Armstrong infection of both B6 and PKO mice. This mobilization of virus-specific CD8 T cells results in up-regulation of the activation-associated isoform of CD43 on the responding cells. More marked divergence between the responses in acutely and chronically infected hosts becomes noticeable during the second week following infection. Arguably, the most fundamental difference between B6 and PKO mice at this stage is the presence of replicating virus in PKO mice. As LCMV is cleared from B6 mice, the CD8 T cell response contracts, and the infectious event concludes with the emergence of resting virus-specific memory cells. The numbers of virus-specific CD8 T cells also decline in PKO mice; nevertheless, the virus-specific CD8 T cells that remain exhibit striking differences in their activation profiles, as they continue to express high levels of CD43 (1B11) and are larger in size (Fig. 2, a and b). These observations are consistent with the idea that a programmed contraction of CD8 T cell responses can occur during the initial phase of chronic infections, but that continued exposure to viral Ag sustains the activated state of the surviving cells (55, 56). In addition to its primary role in cell-mediated cytotoxicity, perforin has been reported to play a role in regulating CD8 T cell homeostasis (reviewed in Ref. 57). Therefore, it is possible that the alterations in the activation state and magnitude of LCMV-specific CD8 T cell responses that occur in PKO mice may be due to a compounding effect of high viral loads superimposed on a host with altered T cell homeostasis. Nevertheless, changes in viral epitope hierarchies and loss of T cell effector functions have also been shown to occur in persistently infected hosts that express perforin (29).

We have shown that virus persistence is associated with changes in the viral epitope hierarchy, and this appears to be a consequence of differential contraction of certain epitope-specific CD8 T cell responses. Our data also suggest that the preferred maintenance of gp276–286-specific CD8 T cells in chronically infected hosts does not result from selection or preferential outgrowth of particular clones of T cells. Both TCR V10 and V8.1/8.2 were predominantly used by gp276–286-specific CD8 T cells, regardless of whether they were effector, memory, or functionally unresponsive CD8 T cells (Fig. 5). Although the exact determinants of immunodominance remain unclear, it is likely that various parameters contribute to the size of each individual epitope-specific response. These factors may include the abundance of Ag, the type of cells that are presenting the Ag, the temporal order of Ag presentation, the stability of the MHC-peptide complex, and competition between dominant and subdominant clones as they encounter APC (58, 59, 60). It has been previously documented that changes in the hierarchy of LCMV-specific CD8 T cell responses can occur as a result of the cell type presenting the viral Ag (61). In the context of the current study, this implies that changes in viral tropism, which can occur in chronically infected hosts, may influence the magnitude of epitope-specific T cell responses (62). The shifts in immunodominance due to altered contraction of responses in chronically infected hosts may have implications for interpreting which specificities of CD8 T cells are most important for initially controlling the acute phase of chronic viral infections. Epitopes ascribed as immunodominant at later time points in chronically infected hosts may not necessarily represent the specificities of CD8 T cells that play a principal role in initially dampening the infection (7, 30, 63).

A central finding of the current study is that although virus-specific CD8 T cells can be induced in persistently infected hosts, their anti-viral effector activities become silenced. In acutely infected hosts, virus-specific CD8 T cells have multiple potential effector activities, and there is an excellent correlation between the numbers of virus-specific CD8 T cells identifiable by MHC tetramer staining and those that are revealed by intracellular cytokine analysis for IFN-. At the peak of the response to acute LCMV infection, a significant fraction of the virus-specific CD8 T cells also produce TNF-, and this proportion increases as replicating virus is cleared and the response progresses through the contraction phase. The diminished potential to produce TNF- during the effector phase of the response may reflect down-regulated TNF- expression as a result of recent antigenic activation (53, 64). This Ag-driven cessation of TNF- is further suggested in PKO mice, in which prolonged exposure to high viral loads manifests first as a loss of TNF- production by virus-specific CD8 T cells and subsequently as an extinguishment of IFN- production. The constant exposure of Ag-specific CD8 T cells to high viral loads not only impacts their ability to produce IFN- and TNF-, but also results in dysregulation of IL-2 production by these cells. IL-2 has been reported to up-regulate granzyme A synthesis, and thus lower IL-2 levels may be responsible for the reduced granzyme A content of effector cells from PKO mice (65, 66, 67). Taken together, these data suggest that a progressive and ultimately global misprogramming of the effector activities of CD8 T cells occurs in chronically infected hosts. This may directly result from repeated TCR triggering due to contact with presented Ag or may be because of indirect consequences, such as cytokine deprivation.

We have previously reported that infection of CD4-deficient mice with certain isolates of LCMV induces a life-long infection due to the loss of functional CD8 T cell responses (29). Other studies of persistent LCMV infections of adult mice have also documented defects in virus-specific CD8 T cell responses (38, 68, 69, 70, 71). In this report we have shown that high viral loads are not only associated with marked defects in virus-specific CD8 T cell responses, but also result in impaired virus-specific CD4 T cell functions. Our data show that both acute and chronic LCMV infections elicit Th1-type CD4 T cell responses. During persistent LCMV infection of PKO mice, virus-specific CD4 T cells are initially induced, but these cells are not fully functional by comparison with their counterparts in acutely infected hosts, as these cells fail to produce abundant levels of IL-2. Notably, loss of LCMV-specific CD4 T cell responses has also been reported in other situations where the infection is only slowly controlled or is never cleared (54, 71, 72). A possible scenario is that high viral loads impair virus-specific CD4 T cell responses, and consequently both chronic antigenic stimulation and ineffective CD4 T cell help ablate virus-specific CD8 T cell responses. Virus persistence in the absence of CD4 T cells can ultimately result in the complete loss of virus-specific CD8 T cells, whereas fluxes in viral loads in chronically infected B6 mice may result in the partial restoration of at least certain CD8 T cell effector functions (M. J. Fuller and A. J. Zajac, unpublished observations). This further supports the idea that both high Ag load and poor CD4 T cell responses contribute to the overall impairment of virus-specific CD8 T cells in chronically infected hosts.

Impairment of CD4 and CD8 T cell responses not only occurs during LCMV infection of mice. Lee et al. (73) reported that 2% of peripheral CD8 T cells were tumor-associated Ag-specific in a patient with metastatic melanoma, but were unable to ascribe any effector activity to this population. Varying defects in effector functions have also been reported for HIV-specific CD8 T cells, and in the case of hepatitis C virus infection, a transient "stunned" loss of effector functions and also more long term dysfunction of CD8 T cell responses have been reported (8, 9, 28, 36, 74, 75). In addition, robust CD4 T cell responses are associated with better control of chronic viral infections. In each of these situations impaired functional activity is associated with difficulties in clearing the Ag. Thus, strategies to boost CD4 T cell activity and decrease Ag loads may help to sustain the functions of the more effective specificities of CD8 T cells. CD4 T cell responses could be potentially enhanced by prophylactic or therapeutic vaccination strategies, and a variety of approaches could be employed to lower viral loads. For experimental studies in LCMV-infected mice, viral loads could potentially be reduced by passive transfer of neutralizing Abs, by adoptive immunotherapy using immune T cells, or by chemotherapeutic approaches. Using such methods may help to further dissect the roles of high viral loads and ineffective CD4 T cell responses in functionally inactivating CD8 T cells. Although the exact biological consequences of aberrant CD4 and CD8 T cell responses remain ill defined, it is likely that pathogenic infections as well as tumor outgrowth will be more successfully controlled by multi-epitope-specific and multifunctional T cell responses.

	Acknowledgments

 
We thank Roger Harris for excellent technical assistance, and Aaruni Khanolkar, Daniel Quinn, and Laurie Harrington for helpful discussions. We also thank Rafi Ahmed for supplying viral seed stocks, and John Altman and the University of Alabama Center for AIDS Research Molecular Biology Core for advice and assistance with MHC-tetramer production.

	Footnotes

 
¹ This work was supported by National Institutes of Health Grant AI49360. M.J.F. was supported in part by Training Grant AI07150.

² Address correspondence and reprint requests to Dr. Allan J. Zajac, Department of Microbiology, University of Alabama, 845 Nineteenth Street South, 446 BBRB-23, Birmingham, AL 35294-2170. E-mail address: azajac{at}uab.edu

³ Abbreviations used in this paper: LCMV, lymphocytic choriomeningitis virus; BLT, N-benzyloxycarbonyl-L-lysine thiobenzyl ester, hydrochloride; NP, nucleoprotein; PKO, perforin-knockout.

Received for publication July 29, 2002. Accepted for publication November 1, 2002.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Whitton, J. L., M. B. A. Oldstone. 2001. The immune response to viruses. D. M. Knipe, and P. M. Howley, and D. E. Griffin, and R. A. Lamb, and M. A. Martin, and B. Roizman, eds. Fundamental Virology 285. Lippincott Williams & Wilkins, Philadelphia.
2. Oxenius, A., R. M. Zinkernagel, H. Hengartner. 1998. CD4⁺ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections. Adv. Immunol. 70:313.[Medline]
3. Harty, J. T., A. R. Tvinnereim, D. W. White. 2000. CD8⁺ T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18:275.[Medline]
4. Doherty, P. C., J. P. Christensen. 2000. Accessing complexity: the dynamics of virus-specific T cell responses. Annu. Rev. Immunol. 18:561.[Medline]
5. Planz, O., S. Ehl, E. Furrer, E. Horvath, M. A. Brundler, H. Hengartner, R. M. Zinkernagel. 1997. A critical role for neutralizing-antibody-producing B cells, CD4⁺ T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94:6874.[Abstract/Free Full Text]
6. Welsh, R. M.. 2000. Lymphocytic choriomeningitis virus as a model for the study of cellular immunology. M. W. Cunningham, and R. S. Fujinami, eds. Effects of Microbes on the Immune System 289. Lippincott Williams & Wilkins, Philadelphia.
7. Pantaleo, G., H. Soudeyns, J. F. Demarest, M. Vaccarezza, C. Graziosi, S. Paolucci, M. Daucher, O. J. Cohen, F. Denis, W. E. Biddison, et al 1997. Evidence for rapid disappearance of initially expanded HIV-specific CD8⁺ T cell clones during primary HIV infection. Proc. Natl. Acad. Sci. USA 94:9848.[Abstract/Free Full Text]
8. Gruener, N. H., F. Lechner, M. C. Jung, H. Diepolder, T. Gerlach, G. Lauer, B. Walker, J. Sullivan, R. Phillips, G. R. Pape, et al 2001. Sustained dysfunction of antiviral CD8⁺ T lymphocytes after infection with hepatitis C virus. J. Virol. 75:5550.[Abstract/Free Full Text]
9. Appay, V., D. F. Nixon, S. M. Donahoe, G. M. Gillespie, T. Dong, A. King, G. S. Ogg, H. M. Spiegel, C. Conlon, C. A. Spina, et al 2000. HIV-specific CD8⁺ T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63.[Abstract/Free Full Text]
10. Welsh, R. M.. 2001. Assessing CD8 T cell number and dysfunction in the presence of antigen. J. Exp. Med. 193:F19.
11. Ploegh, H. L.. 1998. Viral strategies of immune evasion. Science 280:248.[Abstract/Free Full Text]
12. Butz, E. A., M. J. Bevan. 1998. Massive expansion of antigen-specific CD8⁺ T cells during an acute virus infection. Immunity 8:167.[Medline]
13. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.[Medline]
14. Flynn, K. J., G. T. Belz, J. D. Altman, R. Ahmed, D. L. Woodland, P. C. Doherty. 1998. Virus-specific CD8⁺ T cells in primary and secondary influenza pneumonia. Immunity 8:683.[Medline]
15. Callan, M. F., L. Tan, N. Annels, G. S. Ogg, J. D. Wilson, C. A. O’Callaghan, N. Steven, A. J. McMichael, A. B. Rickinson. 1998. Direct visualization of antigen-specific CD8⁺ T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1395.[Abstract/Free Full Text]
16. Stevenson, P. G., G. T. Belz, J. D. Altman, P. C. Doherty. 1998. Virus-specific CD8⁺ T cell numbers are maintained during -herpesvirus reactivation in CD4-deficient mice. Proc. Natl. Acad. Sci. USA 95:15565.[Abstract/Free Full Text]
17. Lin, M. Y., R. M. Welsh. 1998. Stability and diversity of T cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice. J. Exp. Med. 188:1993.[Abstract/Free Full Text]
18. Blattman, J. N., D. J. Sourdive, K. Murali-Krishna, R. Ahmed, J. D. Altman. 2000. Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection. J. Immunol. 165:6081.[Abstract/Free Full Text]
19. Homann, D., L. Teyton, M. B. Oldstone. 2001. Differential regulation of antiviral T-cell immunity results in stable CD8⁺ but declining CD4⁺ T-cell memory. Nat. Med. 7:913.[Medline]
20. Sourdive, D. J., K. Murali-Krishna, J. D. Altman, A. J. Zajac, J. K. Whitmire, C. Pannetier, P. Kourilsky, B. Evavold, A. Sette, R. Ahmed. 1998. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med. 188:71.[Abstract/Free Full Text]
21. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.[Medline]
22. Muller, C., D. Kagi, T. Aebischer, B. Odermatt, W. Held, E. R. Podack, R. M. Zinkernagel, H. Hengartner. 1989. Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. Eur. J. Immunol. 19:1253.[Medline]
23. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. Huang, J. D. Young, R. Ahmed, W. R. Clark. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 91:10854.[Abstract/Free Full Text]
24. Kagi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, R. M. Zinkernagel, H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:3256.[Medline]
25. Heusel, J. W., R. L. Wesselschmidt, S. Shresta, J. H. Russell, T. J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977.[Medline]
26. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25.[Medline]
27. Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825.[Abstract/Free Full Text]
28. Lechner, F., D. K. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191:1499.[Abstract/Free Full Text]
29. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205.[Abstract/Free Full Text]
30. Davenport, M. P., C. Fazou, A. J. McMichael, M. F. Callan. 2002. Clonal selection, clonal senescence, and clonal succession: the evolution of the T cell response to infection with a persistent virus. J. Immunol. 168:3309.[Abstract/Free Full Text]
31. Appay, V., P. R. Dunbar, M. Callan, P. Klenerman, G. M. Gillespie, L. Papagno, G. S. Ogg, A. King, F. Lechner, C. A. Spina, et al 2002. Memory CD8⁺ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8:379.[Medline]
32. Champagne, P., G. S. Ogg, A. S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G. P. Rizzardi, S. Fleury, M. Lipp, et al 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106.[Medline]
33. O’Connor, D. H., T. M. Allen, T. U. Vogel, P. Jing, I. P. DeSouza, E. Dodds, E. J. Dunphy, C. Melsaether, B. Mothe, H. Yamamoto, et al 2002. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat. Med. 8:493.[Medline]
34. Weiner, A., A. L. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A. L. Hughes, M. Houghton, C. M. Walker. 1995. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA 92:2755.[Abstract/Free Full Text]
35. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, et al 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403.[Medline]
36. Kostense, S., K. Vandenberghe, J. Joling, D. Van Baarle, N. Nanlohy, E. Manting, F. Miedema. 2002. Persistent numbers of tetramer⁺ CD8⁺ T cells, but loss of interferon-⁺ HIV-specific T cells during progression to AIDS. Blood 99:2505.[Abstract/Free Full Text]
37. Goepfert, P. A., A. Bansal, B. H. Edwards, G. D. Ritter, Jr, I. Tellez, S. A. McPherson, S. Sabbaj, M. J. Mulligan. 2000. A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce interferon. J. Virol. 74:10249.[Abstract/Free Full Text]
38. Moskophidis, D., F. Lechner, H. Pircher, R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758.[Medline]
39. Moser, J. M., J. D. Altman, A. E. Lukacher. 2001. Antiviral CD8⁺ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells. J. Exp. Med. 193:595.[Abstract/Free Full Text]
40. DeKruyff, R. H., L. V. Rizzo, D. T. Umetsu. 1993. Induction of immunoglobulin synthesis by CD4⁺ T cell clones. Semin. Immunol. 5:421.[Medline]
41. Battegay, M., D. Moskophidis, A. Rahemtulla, H. Hengartner, T. W. Mak, R. M. Zinkernagel. 1994. Enhanced establishment of a virus carrier state in adult CD4⁺ T-cell-deficient mice. J. Virol. 68:4700.[Abstract/Free Full Text]
42. Matloubian, M., R. J. Concepcion, R. Ahmed. 1994. CD4⁺ T cells are required to sustain CD8⁺ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056.[Abstract/Free Full Text]
43. Buchmeier, M. J., A. J. Zajac. 1999. Lymphocytic choriomeningitis virus. R. Ahmed, Jr, and I. S. Y. Chen, Jr, eds. Persistent Viral Infections 575. John Wiley & Sons, Boston.
44. Ahmed, R., A. Salmi, L. D. Butler, J. M. Chiller, M. B. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:521.[Abstract/Free Full Text]
45. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.[Abstract/Free Full Text]
46. Zajac, A. J., R. E. Vance, W. Held, D. J. Sourdive, J. D. Altman, D. H. Raulet, R. Ahmed. 1999. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. J. Immunol. 163:5526.[Abstract/Free Full Text]
47. Takayama, H., G. Trenn, M. V. Sitkovsky. 1987. A novel cytotoxic T lymphocyte activation assay: optimized conditions for antigen receptor triggered granule enzyme secretion. J. Immunol. Methods 104:183.[Medline]
48. Frederick, M. J., T. K. Yu, E. G. Krohn, D. A. Johnston, E. A. Grimm. 1996. Protein tyrosine kinase inhibition blocks granule exocytosis and cytolytic function of lymphokine-activated killer cells. Immunopharmacology 35:83.[Medline]
49. Lowin, B., F. Beermann, A. Schmidt, J. Tschopp. 1994. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91:11571.[Abstract/Free Full Text]
50. Jones, A. T., B. Federsppiel, L. G. Ellies, M. J. Williams, R. Burgener, V. Duronio, C. A. Smith, F. Takei, H. J. Ziltener. 1994. Characterization of the activation-associated isoform of CD43 on murine T lymphocytes. J. Immunol. 153:3426.[Abstract]
51. Harrington, L. E., M. Galvan, L. G. Baum, J. D. Altman, R. Ahmed. 2000. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191:1241.[Abstract/Free Full Text]
52. Slifka, M. K., F. Rodriguez, J. L. Whitton. 1999. Rapid on/off cycling of cytokine production by virus-specific CD8⁺ T cells. Nature 401:76.[Medline]
53. Slifka, M. K., J. L. Whitton. 2000. Activated and memory CD8⁺ T cells can be distinguished by their cytokine profiles and phenotypic markers. J. Immunol. 164:208.[Abstract/Free Full Text]
54. Varga, S. M., R. M. Welsh. 2000. High frequency of virus-specific interleukin-2-producing CD4⁺ T cells and Th1 dominance during lymphocytic choriomeningitis virus infection. J. Virol. 74:4429.[Abstract/Free Full Text]
55. Badovinac, V. P., A. R. Tvinnereim, J. T. Harty. 2000. Regulation of antigen-specific CD8⁺ T cell homeostasis by perforin and interferon-. Science 290:1354.[Abstract/Free Full Text]
56. Badovinac, V. P., B. B. Porter, J. T. Harty. 2002. Programmed contraction of CD8⁺ T cells after infection. Nat. Immunol. 3:619.[Medline]
57. de Saint Basile, G., A. Fischer. 2001. The role of cytotoxicity in lymphocyte homeostasis. Curr. Opin. Immunol. 13:549.[Medline]
58. Gallimore, A., T. Dumrese, H. Hengartner, R. M. Zinkernagel, H. G. Rammensee. 1998. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J. Exp. Med. 187:1647.[Medline]
59. Yewdell, J. W., J. R. Bennink. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17:51.[Medline]
60. Chen, W., L. C. Anton, J. R. Bennink, J. W. Yewdell. 2000. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12:83.[Medline]
61. Butz, E. A., M. J. Bevan. 1998. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells. J. Immunol. 160:2139.[Abstract/Free Full Text]
62. Sevilla, N., S. Kunz, A. Holz, H. Lewicki, D. Homann, H. Yamada, K. P. Campbell, J. C. de La Torre, M. B. Oldstone. 2000. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J. Exp. Med. 192:1249.[Abstract/Free Full Text]
63. Goulder, P. J., M. A. Altfeld, E. S. Rosenberg, T. Nguyen, Y. Tang, R. L. Eldridge, M. M. Addo, S. He, J. S. Mukherjee, M. N. Phillips, et al 2001. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 193:181.[Abstract/Free Full Text]
64. Badovinac, V. P., G. A. Corbin, J. T. Harty. 2000. Cutting edge: OFF cycling of TNF production by antigen-specific CD8⁺ T cells is antigen independent. J. Immunol. 165:5387.[Abstract/Free Full Text]
65. Liu, C. C., S. Rafii, A. Granelli-Piperno, J. A. Trapani, J. D. Young. 1989. Perforin and serine esterase gene expression in stimulated human T cells: kinetics, mitogen requirements, and effects of cyclosporin A. J. Exp. Med. 170:2105.[Abstract/Free Full Text]
66. Hameed, A., D. M. Lowrey, M. Lichtenheld, E. R. Podack. 1988. Characterization of three serine esterases isolated from human IL-2 activated killer cells. J. Immunol. 141:3142.[Abstract]
67. Ye, W., J. D. Young, C. C. Liu. 1996. Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes. Cell. Immunol. 174:54.[Medline]
68. Zhou, S., R. Ou, L. Huang, D. Moskophidis. 2002. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection. J. Virol. 76:829.[Abstract/Free Full Text]
69. Ou, R., S. Zhou, L. Huang, D. Moskophidis. 2001. Critical role for / and interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 75:8407.[Abstract/Free Full Text]
70. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Pluckthun, T. Elliott, H. Hengartner, R. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1383.[Abstract/Free Full Text]
71. Oxenius, A., R. M. Zinkernagel, H. Hengartner. 1998. Comparison of activation versus induction of unresponsiveness of virus-specific CD4⁺ and CD8⁺ T cells upon acute versus persistent viral infection. Immunity 9:449.[Medline]
72. Kamperschroer, C., D. G. Quinn. 2002. The role of proinflammatory cytokines in wasting disease during lymphocytic choriomeningitis virus infection. J. Immunol. 169:340.[Abstract/Free Full Text]
73. Lee, P. P., C. Yee, P. A. Savage, L. Fong, D. Brockstedt, J. S. Weber, D. Johnson, S. Swetter, J. Thompson, P. D. Greenberg, et al 1999. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5:677.[Medline]
74. Spiegel, H. M., G. S. Ogg, E. DeFalcon, M. E. Sheehy, S. Monard, P. A. Haslett, G. Gillespie, S. M. Donahoe, H. Pollack, W. Borkowsky, et al 2000. Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4⁺ T cells. J. Virol. 74:1018.[Abstract/Free Full Text]
75. Rosenberg, E. S., J. M. Billingsley, A. M. Caliendo, S. L. Boswell, P. E. Sax, S. A. Kalams, B. D. Walker. 1997. Vigorous HIV-1-specific CD4⁺ T cell responses associated with control of viremia. Science 278:1447.[Abstract/Free Full Text]

This article has been cited by other articles:

				H. Elsaesser, K. Sauer, and D. G. Brooks IL-21 Is Required to Control Chronic Viral Infection Science, June 19, 2009; 324(5934): 1569 - 1572. [Abstract] [Full Text] [PDF]

				C. M. Bucks, J. A. Norton, A. C. Boesteanu, Y. M. Mueller, and P. D. Katsikis Chronic Antigen Stimulation Alone Is Sufficient to Drive CD8+ T Cell Exhaustion J. Immunol., June 1, 2009; 182(11): 6697 - 6708. [Abstract] [Full Text] [PDF]

				E. L. Turnbull, M. Wong, S. Wang, X. Wei, N. A. Jones, K. E. Conrod, D. Aldam, J. Turner, P. Pellegrino, B. F. Keele, et al. Kinetics of Expansion of Epitope-Specific T Cell Responses during Primary HIV-1 Infection J. Immunol., June 1, 2009; 182(11): 7131 - 7145. [Abstract] [Full Text] [PDF]

				C. Dow, C. Oseroff, B. Peters, C. Nance-Sotelo, J. Sidney, M. Buchmeier, A. Sette, and B. R. Mothe Lymphocytic Choriomeningitis Virus Infection Yields Overlapping CD4+ and CD8+ T-Cell Responses J. Virol., December 1, 2008; 82(23): 11734 - 11741. [Abstract] [Full Text] [PDF]

				M.-G. de Goer de Herve, A. Cariou, F. Simonetta, and Y. Taoufik Heterospecific CD4 Help to Rescue CD8 T Cell Killers J. Immunol., November 1, 2008; 181(9): 5974 - 5980. [Abstract] [Full Text] [PDF]

				L. M. Bixby and R. L. Tarleton Stable CD8+ T Cell Memory during Persistent Trypanosoma cruzi Infection J. Immunol., August 15, 2008; 181(4): 2644 - 2650. [Abstract] [Full Text] [PDF]

				G. R. B. Bantug, D. Cekinovic, R. Bradford, T. Koontz, S. Jonjic, and W. J. Britt CD8+ T Lymphocytes Control Murine Cytomegalovirus Replication in the Central Nervous System of Newborn Animals J. Immunol., August 1, 2008; 181(3): 2111 - 2123. [Abstract] [Full Text] [PDF]

				P. Sen, W. A. Charini, R. A. Subbramanian, E. R. Manuel, M. J. Kuroda, P. A. Autissier, and N. L. Letvin Clonal Focusing of Epitope-Specific CD8+ T Lymphocytes in Rhesus Monkeys following Vaccination and Simian-Human Immunodeficiency Virus Challenge J. Virol., January 15, 2008; 82(2): 805 - 816. [Abstract] [Full Text] [PDF]

				Y. Sun, S. R. Permar, A. P. Buzby, and N. L. Letvin Memory CD4+ T-Lymphocyte Loss and Dysfunction during Primary Simian Immunodeficiency Virus Infection J. Virol., August 1, 2007; 81(15): 8009 - 8015. [Abstract] [Full Text] [PDF]

				E. Belnoue, P. Fontannaz-Bozzotti, S. Grillet, P.-H. Lambert, and C.-A. Siegrist Protracted Course of Lymphocytic Choriomeningitis Virus WE Infection in Early Life: Induction but Limited Expansion of CD8+ Effector T Cells and Absence of Memory CD8+ T Cells J. Virol., July 15, 2007; 81(14): 7338 - 7350. [Abstract] [Full Text] [PDF]

				B. R. Mothe, B. S. Stewart, C. Oseroff, H.-H. Bui, S. Stogiera, Z. Garcia, C. Dow, M. P. Rodriguez-Carreno, M. Kotturi, V. Pasquetto, et al. Chronic Lymphocytic Choriomeningitis Virus Infection Actively Down-Regulates CD4+ T Cell Responses Directed against a Broad Range of Epitopes J. Immunol., July 15, 2007; 179(2): 1058 - 1067. [Abstract] [Full Text] [PDF]

				J. K. Whitmire, B. Eam, N. Benning, and J. L. Whitton Direct Interferon-{gamma} Signaling Dramatically Enhances CD4+ and CD8+ T Cell Memory J. Immunol., July 15, 2007; 179(2): 1190 - 1197. [Abstract] [Full Text] [PDF]

				S. Wojciechowski, P. Tripathi, T. Bourdeau, L. Acero, H. L. Grimes, J. D. Katz, F. D. Finkelman, and D. A. Hildeman Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis J. Exp. Med., July 9, 2007; 204(7): 1665 - 1675. [Abstract] [Full Text] [PDF]

				S. S. Cush, K. M. Anderson, D. H. Ravneberg, J. L. Weslow-Schmidt, and E. Flano Memory Generation and Maintenance of CD8+ T Cell Function during Viral Persistence J. Immunol., July 1, 2007; 179(1): 141 - 153. [Abstract] [Full Text] [PDF]

				J. C. Tilton, M. R. Luskin, A. J. Johnson, M. Manion, C. W. Hallahan, J. A. Metcalf, M. McLaughlin, R. T. Davey Jr., and M. Connors Changes in Paracrine Interleukin-2 Requirement, CCR7 Expression, Frequency, and Cytokine Secretion of Human Immunodeficiency Virus-Specific CD4+ T Cells Are a Consequence of Antigen Load J. Virol., March 15, 2007; 81(6): 2713 - 2725. [Abstract] [Full Text] [PDF]

				A. Hasegawa, C. Moriya, H. Liu, W. A. Charini, H. C. Vinet, R. A. Subbramanian, P. Sen, N. L. Letvin, and M. J. Kuroda Analysis of TCR{alpha}beta Combinations used by Simian Immunodeficiency Virus-Specific CD8+ T Cells in Rhesus Monkeys: Implications for CTL Immunodominance J. Immunol., March 15, 2007; 178(6): 3409 - 3417. [Abstract] [Full Text] [PDF]

				P. Agnellini, P. Wolint, M. Rehr, J. Cahenzli, U. Karrer, and A. Oxenius Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection PNAS, March 13, 2007; 104(11): 4565 - 4570. [Abstract] [Full Text] [PDF]

				S.-A. Younes, L. Trautmann, B. Yassine-Diab, L. H. Kalfayan, A.-E. Kernaleguen, T. O. Cameron, R. Boulassel, L. J. Stern, J.-P. Routy, Z. Grossman, et al. The Duration of Exposure to HIV Modulates the Breadth and the Magnitude of HIV-Specific Memory CD4+ T Cells J. Immunol., January 15, 2007; 178(2): 788 - 797. [Abstract] [Full Text] [PDF]

				A. Charalambous, M. Oks, G. Nchinda, S. Yamazaki, and R. M. Steinman Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin J. Immunol., December 15, 2006; 177(12): 8410 - 8421. [Abstract] [Full Text] [PDF]

				S. Crotty, M. M. McCausland, R. D. Aubert, E. J. Wherry, and R. Ahmed Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease Blood, November 1, 2006; 108(9): 3085 - 3093. [Abstract] [Full Text] [PDF]

				J. M. Grayson, A. E. Weant, B. C. Holbrook, and D. Hildeman Role of Bim in Regulating CD8+ T-Cell Responses during Chronic Viral Infection. J. Virol., September 1, 2006; 80(17): 8627 - 8638. [Abstract] [Full Text] [PDF]

				J. S. Yi, B. C. Holbrook, R. D. Michalek, N. G. Laniewski, and J. M. Grayson Electron Transport Complex I Is Required for CD8+ T Cell Function J. Immunol., July 15, 2006; 177(2): 852 - 862. [Abstract] [Full Text] [PDF]

				M. J. Cayabyab, A.-H. Hovav, T. Hsu, G. R. Krivulka, M. A. Lifton, D. A. Gorgone, G. J. Fennelly, B. F. Haynes, W. R. Jacobs Jr., and N. L. Letvin Generation of CD8+ T-Cell Responses by a Recombinant Nonpathogenic Mycobacterium smegmatis Vaccine Vector Expressing Human Immunodeficiency Virus Type 1 Env J. Virol., February 15, 2006; 80(4): 1645 - 1652. [Abstract] [Full Text] [PDF]

				P. Storm, C. Bartholdy, M. R. Sorensen, J. P. Christensen, and A. R. Thomsen Perforin-Deficient CD8+ T Cells Mediate Fatal Lymphocytic Choriomeningitis despite Impaired Cytokine Production J. Virol., February 1, 2006; 80(3): 1222 - 1230. [Abstract] [Full Text] [PDF]

				B. E. Palmer, N. Blyveis, A. P. Fontenot, and C. C. Wilson Functional and Phenotypic Characterization of CD57+CD4+ T Cells and Their Association with HIV-1-Induced T Cell Dysfunction J. Immunol., December 15, 2005; 175(12): 8415 - 8423. [Abstract] [Full Text] [PDF]

				T. J. Scriba, M. Purbhoo, C. L. Day, N. Robinson, S. Fidler, J. Fox, J. N. Weber, P. Klenerman, A. K. Sewell, and R. E. Phillips Ultrasensitive Detection and Phenotyping of CD4+ T Cells with Optimized HLA Class II Tetramer Staining J. Immunol., November 15, 2005; 175(10): 6334 - 6343. [Abstract] [Full Text] [PDF]

				A. E. Tebo, M. J. Fuller, D. E. Gaddis, K. Kojima, K. Rehani, and A. J. Zajac Rapid Recruitment of Virus-Specific CD8 T Cells Restructures Immunodominance during Protective Secondary Responses J. Virol., October 15, 2005; 79(20): 12703 - 12713. [Abstract] [Full Text] [PDF]

				D. G. Brooks, L. Teyton, M. B. A. Oldstone, and D. B. McGavern Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral Infection J. Virol., August 15, 2005; 79(16): 10514 - 10527. [Abstract] [Full Text] [PDF]

				D. G. Fraser, S. R. Leib, B. S. Zhang, R. H. Mealey, W. C. Brown, and T. C. McGuire Lymphocyte Proliferation Responses Induced to Broadly Reactive Th Peptides Did Not Protect against Equine Infectious Anemia Virus Challenge Clin. Vaccine Immunol., August 1, 2005; 12(8): 983 - 993. [Abstract] [Full Text] [PDF]

				E. J. Wherry, J. N. Blattman, and R. Ahmed Low CD8 T-Cell Proliferative Potential and High Viral Load Limit the Effectiveness of Therapeutic Vaccination J. Virol., July 15, 2005; 79(14): 8960 - 8968. [Abstract] [Full Text] [PDF]

				F. Benigni, V. S. Zimmermann, S. Hugues, S. Caserta, V. Basso, L. Rivino, E. Ingulli, L. Malherbe, N. Glaichenhaus, and A. Mondino Phenotype and Homing of CD4 Tumor-Specific T Cells Is Modulated by Tumor Bulk J. Immunol., July 15, 2005; 175(2): 739 - 748. [Abstract] [Full Text] [PDF]

				V. Lazarevic, D. Nolt, and J. L. Flynn Long-Term Control of Mycobacterium tuberculosis Infection Is Mediated by Dynamic Immune Responses J. Immunol., July 15, 2005; 175(2): 1107 - 1117. [Abstract] [Full Text] [PDF]

				A. K. Nussbaum, M. P. Rodriguez-Carreno, N. Benning, J. Botten, and J. L. Whitton Immunoproteasome-Deficient Mice Mount Largely Normal CD8+ T Cell Responses to Lymphocytic Choriomeningitis Virus Infection and DNA Vaccination J. Immunol., July 15, 2005; 175(2): 1153 - 1160. [Abstract] [Full Text] [PDF]

				C. C. Kemball, E. D. H. Lee, V. Vezys, T. C. Pearson, C. P. Larsen, and A. E. Lukacher Late Priming and Variability of Epitope-Specific CD8+ T Cell Responses during a Persistent Virus Infection J. Immunol., June 15, 2005; 174(12): 7950 - 7960. [Abstract] [Full Text] [PDF]

				M. J. Fuller, D. A. Hildeman, S. Sabbaj, D. E. Gaddis, A. E. Tebo, L. Shang, P. A. Goepfert, and A. J. Zajac Cutting Edge: Emergence of CD127high Functionally Competent Memory T Cells Is Compromised by High Viral Loads and Inadequate T Cell Help J. Immunol., May 15, 2005; 174(10): 5926 - 5930. [Abstract] [Full Text] [PDF]

				Y. Sun, J. E. Schmitz, P. M. Acierno, S. Santra, R. A. Subbramanian, D. H. Barouch, D. A. Gorgone, M. A. Lifton, K. R. Beaudry, K. Manson, et al. Dysfunction of Simian Immunodeficiency Virus/Simian Human Immunodeficiency Virus-Induced IL-2 Expression by Central Memory CD4+ T Lymphocytes J. Immunol., April 15, 2005; 174(8): 4753 - 4760. [Abstract] [Full Text] [PDF]

				C. Beadling and M. K. Slifka Differential regulation of virus-specific T-cell effector functions following activation by peptide or innate cytokines Blood, February 1, 2005; 105(3): 1179 - 1186. [Abstract] [Full Text] [PDF]

				E. Boritz, B. E. Palmer, and C. C. Wilson Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD4+ T Cells That Proliferate In Vitro Detected in Samples from Most Viremic Subjects and Inversely Associated with Plasma HIV-1 Levels J. Virol., November 15, 2004; 78(22): 12638 - 12646. [Abstract] [Full Text] [PDF]

				N. G. Laniewski and J. M. Grayson Antioxidant Treatment Reduces Expansion and Contraction of Antigen-Specific CD8+ T Cells during Primary but Not Secondary Viral Infection J. Virol., October 15, 2004; 78(20): 11246 - 11257. [Abstract] [Full Text] [PDF]

				X. Z. Wang, M. A. Brehm, and R. M. Welsh Preapoptotic Phenotype of Viral Epitope-Specific CD8 T Cells Precludes Memory Development and Is an Intrinsic Property of the Epitope J. Immunol., October 15, 2004; 173(8): 5138 - 5147. [Abstract] [Full Text] [PDF]

				A. Sanchez, M. Lukwiya, D. Bausch, S. Mahanty, A. J. Sanchez, K. D. Wagoner, and P. E. Rollin Analysis of Human Peripheral Blood Samples from Fatal and Nonfatal Cases of Ebola (Sudan) Hemorrhagic Fever: Cellular Responses, Virus Load, and Nitric Oxide Levels J. Virol., October 1, 2004; 78(19): 10370 - 10377. [Abstract] [Full Text] [PDF]

				M. Basler, N. Youhnovski, M. van den Broek, M. Przybylski, and M. Groettrup Immunoproteasomes Down-Regulate Presentation of a Subdominant T Cell Epitope from Lymphocytic Choriomeningitis Virus J. Immunol., September 15, 2004; 173(6): 3925 - 3934. [Abstract] [Full Text] [PDF]

				J. A. Rutigliano and B. S. Graham Prolonged Production of TNF-{alpha} Exacerbates Illness during Respiratory Syncytial Virus Infection J. Immunol., September 1, 2004; 173(5): 3408 - 3417. [Abstract] [Full Text] [PDF]

				E. J. Wherry and R. Ahmed Memory CD8 T-Cell Differentiation during Viral Infection J. Virol., June 1, 2004; 78(11): 5535 - 5545. [Full Text] [PDF]

				E. R. Piriou, K. van Dort, N. M. Nanlohy, F. Miedema, M. H. van Oers, and D. van Baarle Altered EBV Viral Load Setpoint after HIV Seroconversion Is in Accordance with Lack of Predictive Value of EBV Load for the Occurrence of AIDS-Related Non-Hodgkin Lymphoma J. Immunol., June 1, 2004; 172(11): 6931 - 6937. [Abstract] [Full Text] [PDF]

				S. Zhou, R. Ou, L. Huang, G. E. Price, and D. Moskophidis Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection J. Virol., April 1, 2004; 78(7): 3578 - 3600. [Abstract] [Full Text] [PDF]

				M. J. Fuller, A. Khanolkar, A. E. Tebo, and A. J. Zajac Maintenance, Loss, and Resurgence of T Cell Responses During Acute, Protracted, and Chronic Viral Infections J. Immunol., April 1, 2004; 172(7): 4204 - 4214. [Abstract] [Full Text] [PDF]

				A. Khanolkar, M. J. Fuller, and A. J. Zajac CD4 T Cell-Dependent CD8 T Cell Maturation J. Immunol., March 1, 2004; 172(5): 2834 - 2844. [Abstract] [Full Text] [PDF]

				S.-K. Kim and R. M. Welsh Comprehensive Early and Lasting Loss of Memory CD8 T Cells and Functional Memory during Acute and Persistent Viral Infections J. Immunol., March 1, 2004; 172(5): 3139 - 3150. [Abstract] [Full Text] [PDF]

				B. E. Palmer, E. Boritz, and C. C. Wilson Effects of Sustained HIV-1 Plasma Viremia on HIV-1 Gag-Specific CD4+ T Cell Maturation and Function J. Immunol., March 1, 2004; 172(5): 3337 - 3347. [Abstract] [Full Text] [PDF]

				K. Tewari, J. Sacha, X. Gao, and M. Suresh Effect of Chronic Viral Infection on Epitope Selection, Cytokine Production, and Surface Phenotype of CD8 T Cells and the Role of IFN-{gamma} Receptor in Immune Regulation J. Immunol., February 1, 2004; 172(3): 1491 - 1500. [Abstract] [Full Text] [PDF]

				K. Abel, L. La Franco-Scheuch, T. Rourke, Z.-M. Ma, V. de Silva, B. Fallert, L. Beckett, T. A. Reinhart, and C. J. Miller Gamma Interferon-Mediated Inflammation Is Associated with Lack of Protection from Intravaginal Simian Immunodeficiency Virus SIVmac239 Challenge in Simian-Human Immunodeficiency Virus 89.6-Immunized Rhesus Macaques J. Virol., January 15, 2004; 78(2): 841 - 854. [Abstract] [Full Text] [PDF]

				C. L. Day and B. D. Walker Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections J. Exp. Med., December 15, 2003; 198(12): 1773 - 1777. [Full Text] [PDF]

				S.-A. Younes, B. Yassine-Diab, A. R. Dumont, M.-R. Boulassel, Z. Grossman, J.-P. Routy, and R.-P. Sekaly HIV-1 Viremia Prevents the Establishment of Interleukin 2-producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity J. Exp. Med., December 15, 2003; 198(12): 1909 - 1922. [Abstract] [Full Text] [PDF]

				C. Iyasere, J. C. Tilton, A. J. Johnson, S. Younes, B. Yassine-Diab, R.-P. Sekaly, W. W. Kwok, S. A. Migueles, A. C. Laborico, W. L. Shupert, et al. Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 J. Virol., October 15, 2003; 77(20): 10900 - 10909. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fuller, M. J. Articles by Zajac, A. J. Search for Related Content PubMed PubMed Citation Articles by Fuller, M. J. Articles by Zajac, A. J.